... San Antonio Breast Cancer Symposium (SABCS), taking place December 9–12, 2025 in San Antonio, Texas. Vepdegestrant is a novel investigational ...
News
- Arvinas Announces Data Presentations from the Vepdegestrant (ARV - GuruFocus
- Arvinas Announces Data Presentations from the Vepdegestrant Clinical Development ...
Arvinas, Inc. a clinical-stage biotechnology company creating a ... San Antonio Breast Cancer Symposium taking place December 9–12, 2025 in ...
- Osisko Development Announces Agreement to Divest Non-Core San Antonio Gold Project
... Biotechnology Stocks · Cannabis Stocks · Clean Energy Stocks · Crypto ... (TSXV:AXO) ("Axo") to sell its 100% interest in the San Antonio Gold ...
- Osisko Development Sells Mexican Gold Project To Axo Copper - Finimize
The company shifts focus to core assets while keeping a stake in future San Antonio gains through shareholding and contingency payments.
- CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative ...
Gonzalez Convention Center in San Antonio, Texas. Currently, mTNBC is associated with a poor prognosis. The efficacy of immune checkpoint inhibitors ( ...